EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Magnera Corp placeholder (MAGN) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Magnera Corp placeholder $35.46, price $11.82, upside +200.0%, quality 32 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Consumer Defensive · US · ISIN US55939A1079

MC Magnera Corp placeholder logo Thin data Sep 23, 2026

Magnera Corp placeholder

MAGN · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value $35.46 · Strongly undervalued (+200%)
!Quality 32/100
!Mixed Growth (revenue 5y +28.4 %/yr)
!Loss-making · -3.4% net margin (TTM)
✓Moderate debt · generates free cash flow
!Trails peers (4/13)
!Narrow moat 24/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$233.33 $7.96 Fair Value $35.46 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $7.96 – $233.33 · fair‑value band $14.84 – $56.07 · the $11.82 price screens below the $35.46 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 3 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 23, 2026.

Follow Magnera Corp placeholder in your weekly email

Every Wednesday you see whether Magnera Corp placeholder is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, and personal care.

Show more

Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, and personal care. The company offers personal care and consumer solution products and components of products including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence. The company also offers tea bags, coffee filters, wipes, cable wrap, filtration, baby diapers and adult incontinence. The company is headquartered in Charlotte, North Carolina.

Stock analysis

Magnera Corp placeholder (MAGN) currently trades at $11.82, while our model-based Fair Value estimate is $35.46, implying the stock looks roughly 66.7% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $53.66 per share, and 11 of the 13 models we run sit above the $11.82 price.

Bear case: the Earnings-Based group reads lowest at $6.21, and 2 of the 13 models stay below the price. Evidence for this calculation is low.

Scenario range: $14.84 (bear) to $56.07 (bull), the price of $11.82 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 32/100 (below-average quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Magnera Corp placeholder reported revenue of $3.2B in FY2025 versus $1.1B in FY2021, a compound +31.1%/yr. Reported net income was −$159M in FY2025.

Key figures

Market cap $420M · P/S ratio 0.13 · EPS (TTM) $−4.47 · Net margin −5.0% · Return on equity −10.3% · Return on assets (EBIT) −2.2% · Operating margin 4.2% · Revenue (TTM) $3.3B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).

What moves the price

The share trades about 23% below its 52-week high and 48% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −14% fair-value upside, at 200%, MAGN screens cheaper than that median.

Fair Value models

Bear $14.84 Fair Value $35.46 Bull $56.07
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $30.90 $53.66 $84.96 79
Growth DCF $30.98 $50.37 $75.19 78
5Y EBITDA Exit $36.93 $70.34 $109.73 73
All 13 models by family
DCF Models
FCF DCF $30.90 $53.66 $84.96 79
5Y Revenue Exit $16.72 $31.75 $50.50 71
5Y EBITDA Exit $36.93 $70.34 $109.73 73
10Y Revenue Exit $21.36 $35.91 $54.94 66
10Y EBITDA Exit $33.87 $60.67 $97.04 67
Earnings-Based
EPV $3.61 $6.21 $8.37 72
Multiples
EV/EBIT $12.33 $21.57 $30.81 64
EV/EBITDA $47.80 $68.87 $89.94 67
EV/Revenue $8.63 $18.93 $29.23 51
Asset-Based
NCAV (Graham) $14.94 $20.02 $29.89 54
Growth DCF
Growth DCF $30.98 $50.37 $75.19 78
Rev-Margin DCF $16.72 $32.23 $50.74 71
Economic Profit
ROIC Compounder $3.61 $6.21 $8.37 70

Open the full fair value analysis →

Notify me when MAGN reaches fair value

Put MAGN on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 32/100

Of which business quality 31 · Market factors (momentum, volatility) 38

Profitability 15
Margins and returns on capital today
Quality Growth 52
Are margins and returns improving?
Cashflow 15
Earnings quality: real cash, not paper profit
Fin. Strength 26
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 4
Calm price path (market factor)
Momentum 56
Price trend over the last 3–12 months (market factor)
52W Momentum 46
Distance to the 52-week high (market factor)
Net Issuance 68
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+46.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+29.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.4%
Start year 2020 (pandemic). Over 10 years: +6.8% a year
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
5.4% (2020) → 2.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+19.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +16.3% a year for the price.

Watch MAGN, get fair value alerts →

Earlier news

News mood ⓘNews mood, the average tone of recent news (71 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.

Compare Magnera Corp placeholder with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 251 stocks

Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 32 · Bottom 25%
Fair Value upside +200% · Top 25%
Profitability
Return on assets 2% · Below median
Net margin (TTM) −3% · Bottom 25%
Operating margin (TTM) 4% · Below median
Growth and dividend
Revenue growth −3% · Below median
Balance sheet
Debt / equity 0.80× · Highest 25%

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/B 0.39× · Cheapest 25%
P/S (TTM) 0.13× · Cheapest 25%
P/FCF 11.7× · Priciest 25%
EV/EBITDA 3.0× · Cheapest 25%
PEG 4.23× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 33
FUTURE (revenue growth)0 · sector 5
PAST (return on equity)0 · sector 27
HEALTH (low debt)60 · sector 98
DIVIDEND (yield)0 · sector 55

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Colgate-Palmolive Company CL $85.93 $55.95 −35%
Hindustan Unilever Limited HINDUNILVR ₹1,950 ₹775.25 −60%
Kenvue Inc KVUE $17.86 $12.73 −29%
Kimberly-Clark Corporation KMB $97.70 $83.93 −14%
Henkel AG HEN €68.50 €80.96 +18%
The Estée Lauder Companies Inc EL $98.83 $27.22 −72%
Church & Dwight Co CHD $96.02 $65.12 −32%
Beiersdorf Aktiengesellschaft, BEI €78.18 €68.95 −12%
Puig Brands, S.A PUIG €17.56 €19.32 +10%
The Clorox Company CLX $87.15 $104.53 +20%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Magnera Corp placeholder Fair Value". https://www.fairvalue-calculator.com/stock/MAGN

Frequently asked questions

Is Magnera Corp placeholder (MAGN) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $35.46 versus a price of $11.82, about +200% upside (undervalued).
What is the fair value of MAGN?
Our model-based fair value for Magnera Corp placeholder is $35.46 (as of Sep 23, 2026), built from audited fundamentals. The current price: $11.82.
What is the quality score of MAGN?
Magnera Corp placeholder has a Quality Score of 32/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Magnera Corp placeholder (MAGN)?
Our model-based price target is the fair value of $35.46 (as of Sep 23, 2026) from 13 valuation models. Cautious scenario $14.84, optimistic scenario $56.07. It is a calculation from audited fundamentals, not an analyst target.
What is the Magnera Corp placeholder stock forecast for 2026?
Our models put fair value at $35.46, about +200% upside versus a price of $11.82 (undervalued). Cautious scenario $14.84, optimistic scenario $56.07. The calculation is refreshed regularly with new filings.
What is the revenue of Magnera Corp placeholder (MAGN)?
Magnera Corp placeholder reported trailing-twelve-month revenue of about $3.3B (latest available figure, as of Sep 23, 2026).
What growth is priced into Magnera Corp placeholder (MAGN)?
For today's price to be fair in a discounted-cash-flow model, Magnera Corp placeholder would have to grow free cash flow by +19.1 % per year for five years (discount rate 11.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +28.4 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of MAGN use?
Our models discount Magnera Corp placeholder at 11.2 %: a base by market capitalisation (small), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Magnera Corp placeholder that is +19.1 % per year a year over ten years, using the same discount rate (11.2 %) and the same formula as our fair value.
How much growth has Magnera Corp placeholder (MAGN) delivered so far?
Over the past 5 years revenue at Magnera Corp placeholder grew +28.4 % a year. The price currently implies +19.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Magnera Corp placeholder (MAGN) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Magnera Corp placeholder (+19.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Magnera Corp placeholder (MAGN)?
The free-cash-flow yield on the price is 8.58 %: that much free cash flow Magnera Corp placeholder produces per unit of market value. When it exceeds the discount rate of our models (11.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Magnera Corp placeholder (MAGN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Magnera Corp placeholder it is $35.46 per share (as of Sep 23, 2026), against a price of $11.82. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Magnera Corp placeholder stock overvalued or undervalued in 2026?
As of Sep 23, 2026, MAGN trades below its calculated fair value: price $11.82, fair value $35.46, a gap of about +200% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MAGN?
No. The price is what the market pays today ($11.82); the fair value is what the company's own numbers justify ($35.46). For Magnera Corp placeholder the two are $23.64 per share apart. That gap is exactly why we show both numbers side by side.
How much is Magnera Corp placeholder worth?
The market values Magnera Corp placeholder at about $420M (market capitalisation, as of Sep 23, 2026). Per share that is $11.82; our models calculate a fair value of $35.46 per share.
What do the bullish and bearish scenarios say about MAGN?
Our models span a range for Magnera Corp placeholder: cautious scenario $14.84, base $35.46, optimistic $56.07 per share (as of Sep 23, 2026, price $11.82). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of MAGN?
The PEG ratio of Magnera Corp placeholder is 4.23 (P/E divided by earnings growth, as of Sep 23, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Magnera Corp placeholder (MAGN)?
Balance-sheet figures for Magnera Corp placeholder (as of Sep 23, 2026): return on equity −10.3%, debt of 0.80 per unit of equity. They feed the Quality Score of 32/100, which measures business quality independently of the share price.
How far is MAGN from its 52-week high?
Magnera Corp placeholder trades at $11.82, about 23% below its 52-week high of $15.26 and 48% above the low of $7.96 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $35.46 is for.
Which stocks are comparable to Magnera Corp placeholder?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, Kimberly-Clark Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Magnera Corp placeholder stock attractive at the current price?
The data as of Sep 23, 2026: price $11.82, calculated fair value $35.46 (+200%), Quality Score 32/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MAGN calculated?
We run Magnera Corp placeholder through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $35.46, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Magnera Corp placeholder currently trades 200 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Magnera Corp placeholder (MAGN)?
The closing price on Sep 23, 2026 was $11.82. Our model-based fair value is $35.46, about +200% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Magnera Corp placeholder right now?
The large discount to fair value meets weak quality (32/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($14.84). The market is more pessimistic than our downside scenario. The model range is unusually wide ($14.84 to $56.07). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Magnera Corp placeholder

How large is the market capitalisation of Magnera Corp placeholder (MAGN)?
The market capitalisation of Magnera Corp placeholder is $420M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Magnera Corp placeholder (MAGN)?
The price-to-sales ratio of Magnera Corp placeholder is 0.13 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Magnera Corp placeholder (MAGN)?
Earnings per share at Magnera Corp placeholder are $−4.47. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Magnera Corp placeholder (MAGN)?
The net margin of Magnera Corp placeholder is −5.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Magnera Corp placeholder (MAGN)?
The return on equity (ROE) of Magnera Corp placeholder is −10.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Magnera Corp placeholder (MAGN)?
On an EBIT basis the return on assets of Magnera Corp placeholder is −2.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Magnera Corp placeholder (MAGN)?
The operating margin of Magnera Corp placeholder is 4.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Magnera Corp placeholder (MAGN)?
Revenue at Magnera Corp placeholder is growing −3.4% versus a year earlier (3y avg +29.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Magnera Corp placeholder (MAGN) carry?
The net debt of Magnera Corp placeholder is $1.7B (fiscal year 2025, ≈ 47.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Magnera Corp placeholder in the live analysis

One click puts Magnera Corp placeholder on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.